Gene targeting in human somatic cells

Research output: Chapter in Book/Report/Conference proceedingChapter

15 Citations (Scopus)

Abstract

Somatic gene targeting in human cells has two general applications of importance and wide interest. One is the inactivation of genes (knockouts), a process utilized to delineate the loss-of-function phenotype(s) of a particular gene. The second application is the process of gene therapy, which involves correcting a pre-existing mutated allele(s) of a gene back to wild-type in order to ameliorate some pathological phenotype associated with the mutation. Both of these processes require a form of DNA double-strand break repair known as homologous recombination. Although bacteria and lower eukaryotes utilize homologous recombination almost exclusively, a competing process, known as nonhomologous end joining, predominates in higher eukaryotes and was presumed to prevent the use of gene targeting in human somatic cells in culture. A series of molecular and technical advances developed in the 1990s disproved this notion, but still resulted in a process that was cumbersome, labor intensive, highly inefficient, and slow. Within the past 5 years, the use of new gene delivery vectors such as recombinant adeno-associated virus and the identification of cell lines such as Nalm-6 that appear to undergo high rates of gene targeting have significantly brightened the outlook for this field and resulted in a gene delivery system that facilitates both gene knockouts and gene therapy modifications at robust levels. Thus, gene targeting in human somatic cells in culture has become not only feasible, but also relatively facile, and it harbingers a golden age for directed mutagenesis.

Original languageEnglish (US)
Title of host publicationSource Book of Models for Biomedical Research
PublisherHumana Press
Pages509-525
Number of pages17
ISBN (Print)9781588299338
DOIs
StatePublished - Dec 1 2008

Fingerprint

Gene Targeting
Gene Knockout Techniques
Homologous Recombination
Eukaryota
Genetic Therapy
Cell Culture Techniques
Genes
Phenotype
Gene Transfer Techniques
Dependovirus
Double-Stranded DNA Breaks
Mutagenesis
Alleles
Bacteria
Cell Line
Mutation

Keywords

  • DNA double-strand breaks
  • Gene knockouts
  • Gene targeting
  • Gene therapy
  • HCT116 cells
  • Homologous recombination
  • NALM-6 cells
  • Nonhomologous end joining
  • Recombinant adeno-associated virus

Cite this

Hendrickson, E. A. (2008). Gene targeting in human somatic cells. In Source Book of Models for Biomedical Research (pp. 509-525). Humana Press. https://doi.org/10.1007/978-1-59745-285-4_53

Gene targeting in human somatic cells. / Hendrickson, Eric A.

Source Book of Models for Biomedical Research. Humana Press, 2008. p. 509-525.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hendrickson, EA 2008, Gene targeting in human somatic cells. in Source Book of Models for Biomedical Research. Humana Press, pp. 509-525. https://doi.org/10.1007/978-1-59745-285-4_53
Hendrickson EA. Gene targeting in human somatic cells. In Source Book of Models for Biomedical Research. Humana Press. 2008. p. 509-525 https://doi.org/10.1007/978-1-59745-285-4_53
Hendrickson, Eric A. / Gene targeting in human somatic cells. Source Book of Models for Biomedical Research. Humana Press, 2008. pp. 509-525
@inbook{52083a4f9f7d4919a7cbc09ea3033f02,
title = "Gene targeting in human somatic cells",
abstract = "Somatic gene targeting in human cells has two general applications of importance and wide interest. One is the inactivation of genes (knockouts), a process utilized to delineate the loss-of-function phenotype(s) of a particular gene. The second application is the process of gene therapy, which involves correcting a pre-existing mutated allele(s) of a gene back to wild-type in order to ameliorate some pathological phenotype associated with the mutation. Both of these processes require a form of DNA double-strand break repair known as homologous recombination. Although bacteria and lower eukaryotes utilize homologous recombination almost exclusively, a competing process, known as nonhomologous end joining, predominates in higher eukaryotes and was presumed to prevent the use of gene targeting in human somatic cells in culture. A series of molecular and technical advances developed in the 1990s disproved this notion, but still resulted in a process that was cumbersome, labor intensive, highly inefficient, and slow. Within the past 5 years, the use of new gene delivery vectors such as recombinant adeno-associated virus and the identification of cell lines such as Nalm-6 that appear to undergo high rates of gene targeting have significantly brightened the outlook for this field and resulted in a gene delivery system that facilitates both gene knockouts and gene therapy modifications at robust levels. Thus, gene targeting in human somatic cells in culture has become not only feasible, but also relatively facile, and it harbingers a golden age for directed mutagenesis.",
keywords = "DNA double-strand breaks, Gene knockouts, Gene targeting, Gene therapy, HCT116 cells, Homologous recombination, NALM-6 cells, Nonhomologous end joining, Recombinant adeno-associated virus",
author = "Hendrickson, {Eric A}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-1-59745-285-4_53",
language = "English (US)",
isbn = "9781588299338",
pages = "509--525",
booktitle = "Source Book of Models for Biomedical Research",
publisher = "Humana Press",

}

TY - CHAP

T1 - Gene targeting in human somatic cells

AU - Hendrickson, Eric A

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Somatic gene targeting in human cells has two general applications of importance and wide interest. One is the inactivation of genes (knockouts), a process utilized to delineate the loss-of-function phenotype(s) of a particular gene. The second application is the process of gene therapy, which involves correcting a pre-existing mutated allele(s) of a gene back to wild-type in order to ameliorate some pathological phenotype associated with the mutation. Both of these processes require a form of DNA double-strand break repair known as homologous recombination. Although bacteria and lower eukaryotes utilize homologous recombination almost exclusively, a competing process, known as nonhomologous end joining, predominates in higher eukaryotes and was presumed to prevent the use of gene targeting in human somatic cells in culture. A series of molecular and technical advances developed in the 1990s disproved this notion, but still resulted in a process that was cumbersome, labor intensive, highly inefficient, and slow. Within the past 5 years, the use of new gene delivery vectors such as recombinant adeno-associated virus and the identification of cell lines such as Nalm-6 that appear to undergo high rates of gene targeting have significantly brightened the outlook for this field and resulted in a gene delivery system that facilitates both gene knockouts and gene therapy modifications at robust levels. Thus, gene targeting in human somatic cells in culture has become not only feasible, but also relatively facile, and it harbingers a golden age for directed mutagenesis.

AB - Somatic gene targeting in human cells has two general applications of importance and wide interest. One is the inactivation of genes (knockouts), a process utilized to delineate the loss-of-function phenotype(s) of a particular gene. The second application is the process of gene therapy, which involves correcting a pre-existing mutated allele(s) of a gene back to wild-type in order to ameliorate some pathological phenotype associated with the mutation. Both of these processes require a form of DNA double-strand break repair known as homologous recombination. Although bacteria and lower eukaryotes utilize homologous recombination almost exclusively, a competing process, known as nonhomologous end joining, predominates in higher eukaryotes and was presumed to prevent the use of gene targeting in human somatic cells in culture. A series of molecular and technical advances developed in the 1990s disproved this notion, but still resulted in a process that was cumbersome, labor intensive, highly inefficient, and slow. Within the past 5 years, the use of new gene delivery vectors such as recombinant adeno-associated virus and the identification of cell lines such as Nalm-6 that appear to undergo high rates of gene targeting have significantly brightened the outlook for this field and resulted in a gene delivery system that facilitates both gene knockouts and gene therapy modifications at robust levels. Thus, gene targeting in human somatic cells in culture has become not only feasible, but also relatively facile, and it harbingers a golden age for directed mutagenesis.

KW - DNA double-strand breaks

KW - Gene knockouts

KW - Gene targeting

KW - Gene therapy

KW - HCT116 cells

KW - Homologous recombination

KW - NALM-6 cells

KW - Nonhomologous end joining

KW - Recombinant adeno-associated virus

UR - http://www.scopus.com/inward/record.url?scp=42249085637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249085637&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-285-4_53

DO - 10.1007/978-1-59745-285-4_53

M3 - Chapter

AN - SCOPUS:42249085637

SN - 9781588299338

SP - 509

EP - 525

BT - Source Book of Models for Biomedical Research

PB - Humana Press

ER -